Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases.
The DOI matches its Crossref record.
Abstract
Immature, rIL-3-dependent mouse bone marrow-derived mast cells (BMMC) contain high steady-state levels of the mouse mast cell protease (mMCP) 5 transcript but undetectable levels of the mMCP-1, mMCP-2, or mMCP-4 transcripts even though all four of their genes reside at a locus on chromosome 14. These mast cells can be induced by recombinant c-kit ligand (rKL) to obtain high steady-state levels of the mMCP-4 transcript and by rIL-10 to obtain high steady-state levels of the mMCP-1 and mMCP-2 transcripts. rIL-3 and rKL both elicit the differentiation of progenitor cells into immature BMMC and then stimulate their proliferation. We now report that although rIL-9 alone has no effect on BMMC proliferation as assessed by their incorporation of [3H]thymidine, rIL-9 in combination with rKL enhances the long term viability of BMMC. Furthermore, rIL-9 in the presence of rKL stimulates mouse BMMC to undergo a phenotypic change by inducing accumulation of high steady-state levels of the mMCP-1 and mMCP-2 transcripts. In contrast, in BMMC, the presence of rIL-4 suppresses the rIL-9-induced accumulation of the mMCP-1 and mMCP-2 transcripts, the rIL-10-induced accumulation of the mMCP-1 and mMCP-2 transcripts, and the rKL-induced accumulation of the mMCP-4 transcript, but not the rIL-3-induced accumulation of the mMCP-5 transcript. The presence of rIL-3 also suppresses the rIL-9-induced accumulation of the mMCP-1 and mMCP-2 transcripts. Because of their counter-regulatory actions on the steady-state levels of transcripts that encode three late-expressed serine proteases in BALB/cJ mice, rIL-4 and rIL-3 both inhibit the final stages of differentiation and maturation of mast cells. Because rIL-4, unlike rIL-3, is neither an inducer of early-expressed proteases nor alone a proliferative factor for BMMC, the counterregulatory actions of rIL-3 and rIL-4 on differentiation and maturation of these mouse mast cells are independent of their other functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 638
Temann, U.-A., Geba, G. P., Rankin, J. A., & Flavell, R. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1307 · Cited by 452
“The in vitro biological functions of IL-9 include its ability to stimulate proliferation of activated T cells (23–25), to enhance production of immunoglobulin in B cells (26, 27), and to promote proliferation and differentiation of mast cells (28, 29) and hematopoietic progenitors (30, 31).”
BackgroundDevelopment, Migration, and Survival of Mast Cells
Okayama, Y., & Kawakami, T. (2006) · Immunologic Research · doi:10.1385/ir:34:2:97 · Cited by 427
Goswami, R., & Kaplan, M. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003049 · Cited by 399
New insights into the role of cytokines in asthma
Renauld, J.-C. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.8.577 · Cited by 384
Developmental Origin and Functional Specialization of Mast Cell Subsets
Gurish, M. F., & Austen, K. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.003 · Cited by 326
Self-citationPejler, G., Åbrink, M., Ringvall, M., & Wernersson, S. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95006-3 · Cited by 320
IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity
Forbes, E. E., Groschwitz, K., Abonia, J. P., Brandt, E. B., Cohen, E., Blanchard, C., Ahrens, R., Seidu, L., McKenzie, A., Strait, R., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071046 · Cited by 295
Interleukin 9: A candidate gene for asthma
Nicolaides, N. C., Holroyd, K. J., Ewart, S. L., Eleff, S. M., Kiser, M. B., Dragwa, C. R., Sullivan, C. D., Grasso, L., Zhang, L.-Y., Messler, C. J., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13175 · Cited by 228
Murakami, M., Matsumoto, R., Austen, K. F., & Arm, J. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31786-6 · Cited by 217
Self-citationPulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology
Temann, U.-A., Ray, P., & Flavell, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213696 · Cited by 201
Cheng, G., Arima, M., Honda, K., Hirata, H., Eda, F., Yoshida, N., Fukushima, F., Ishii, Y., & Fukuda, T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105079 · Cited by 184
McLane, M. P., Haczku, A., van de Rijn, M., Weiss, C., Ferrante, V., MacDonald, D., Renauld, J.-C., Nicolaides, N. C., Holroyd, K. J., & Levitt, R. C. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.5.3457 · Cited by 180
Th9 and other IL-9-producing cells in allergic asthma
Koch, S., Sopel, N., & Finotto, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-016-0601-1 · Cited by 160
Douaiher, J., Succar, J., Lancerotto, L., Gurish, M. F., Orgill, D. P., Hamilton, M. J., Krilis, S. A., & Stevens, R. L. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00006-7 · Cited by 131
Self-citationLineage‐specific regulation of inducible and constitutive mast cells in allergic airway inflammation
Derakhshan, T., Samuchiwal, S. K., Hallen, N., Bankova, L. G., Boyce, J. A., Barrett, N. A., Austen, K. F., & Dwyer, D. F. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20200321 · Cited by 75
Self-citation
Metadata
- Authors
- Eklund, K. K., Ghildyal, N., Austen, K. F., & Stevens, R. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-10
- Volume
- 151
- Issue
- 8
- Pages
- 4266-4273
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1657207959
- Cited by
- 137
- References
- 0
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.